RecruitingNot applicableNCT02098252
Treatment of Brain AVMs (TOBAS) Study
Studying Brain arteriovenous malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Principal Investigator
- Daniel Roy, MDCHUM-Montreal
- Intervention
- Neurosurgery(procedure)
- Enrollment
- 1000 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2014 – 2036
Study locations (30)
- Mayo Clinic in Jacksonville FL, Jacksonville, Florida, United States
- Boston Medical Center, Boston, Massachusetts, United States
- University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
- Hospital Geral de Fortaleza, Fortaleza, Brazil
- Universidade Federal de Sǎo Paulo, São Paulo, Brazil
- University of Alberta Hospital, Edmonton, Alberta, Canada
- Klink, Ruby, Montreal, Quebec, Canada
- Instituto de Neurocirugia Dr. A. Asenjo, Santiago, Chile
- Universidad Autonoma de Bucaramanga, Bucaramanga, Colombia
- CHRU de Brest (Brest University Hospital), Brest, Brittany Region, France
- Centre Hospit Régional Universitaire de Besançon, Besançon, France
- Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
- Centre Hospitalier Universitaire de Caen, Caen, France
- CHU Clermont-Ferrand, Clermont-Ferrand, France
- CHU Dijon Bourgogne, Dijon, France
- +15 more locations on ClinicalTrials.gov
Collaborators
Centre Hospitalier Régional et Universitaire de Brest
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02098252 on ClinicalTrials.govOther trials for Brain arteriovenous malformation
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07519876Pulmonary Embolism and Right-to-Left ShuntsTufts Medical Center
- RECRUITINGPHASE2, PHASE3NCT06264531Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous MalformationsFondation Ophtalmologique Adolphe de Rothschild
- RECRUITINGNCT07118631Clinical Study on Emergency Treatment of Cerebral Arteriovenous Malformation BleedingBeijing Tiantan Hospital
- RECRUITINGPHASE2NCT06913725An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous MalformationsXuanwu Hospital, Beijing
- RECRUITINGNANCT07314047The Liquid Embolic Agent for the Treatment of Brain Arteriovenous MalformationMicroPort NeuroTech Co., Ltd.
- RECRUITINGNCT06259292Comprehensive HHT Outcomes Registry of the United States (CHORUS)Cure HHT
- RECRUITINGNCT05449106Evaluation of Clinical Outcomes of Unruptured bAVMs Treated With Medical Management Alone Based on Multimodal CTBeijing Tiantan Hospital
- RECRUITINGNCT04927156Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up PlatformBalt Extrusion